RxSight, Inc. RXST EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by RxSight, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: RxSight, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about RxSight, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is RxSight, Inc.'s EPS (diluted)?
- RxSight, Inc. (RXST) reported EPS (diluted) of -$0.38 in Q1 2026.
- How has RxSight, Inc.'s EPS (diluted) changed year-over-year?
- RxSight, Inc.'s EPS (diluted) decreased by 90.0% year-over-year, from -$0.20 to -$0.38.
- What is the long-term trend for RxSight, Inc.'s EPS (diluted)?
- Over 3 years (2022 to 2025), RxSight, Inc.'s EPS (diluted) has grown at a -26.7% compound annual growth rate (CAGR), from -$2.41 to -$0.95.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.